Ironwood Pharmaceuticals Inc
IRWD· Nasdaq
No earnings release is on file for this quarter. Its figures came with the 10-K.
| Metric | Q4 2013 | Q4 2012 | Q4 2011 | Q4 2010 |
|---|---|---|---|---|
| Revenue | $5.03M | $26.98M | $32.15M | $16.77M |
| Net Income | — | — | -$6.97M | -$11.65M |
| EPS Diluted | -$0.43 |
Ironwood Pharmaceuticals Inc · CIK 1446847 · Engraved from SEC EDGAR
| -$0.41 |
| -$0.07 |
| -$0.12 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.